We show that TRIM21 is induced in livers of humans and mice with NASH and that TNF-α and FA, the principal promoters of NASH pathogenesis, activate TRIM21 expression in hepatocytes through TAK1/JNK signaling. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatohepatitis.